HRP20170897A2 - Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo - Google Patents
Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvoInfo
- Publication number
- HRP20170897A2 HRP20170897A2 HRP20170897AA HRP20170897A HRP20170897A2 HR P20170897 A2 HRP20170897 A2 HR P20170897A2 HR P20170897A A HRP20170897A A HR P20170897AA HR P20170897 A HRP20170897 A HR P20170897A HR P20170897 A2 HRP20170897 A2 HR P20170897A2
- Authority
- HR
- Croatia
- Prior art keywords
- mupirocin
- viral infections
- pharmaceutical formulation
- antiviral agent
- topical pharmaceutical
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Predmetni izum otkriva farmaceutske formulacije mupirocina (1) ili njegovih farmaceutski prihvatljivih soli ili estera; kao učinkovitih antivirusnih sredstava za upotrebu u topikalnoj terapiji virusnih infekcija kod ljudi i životinja. Formulacije mupirocina prema izumu posebno su učinkovite u topikalnom tretmanu virusnih infekcija Herpes simplex i Herpes zoster.The subject matter of the invention reveals pharmaceutical formulations based on mupirocin (1) or its pharmaceutically acceptable salts or esters, as efficient antiviral agents to be used in topical therapy of viral infections with humans and animals. Formulations based on mupirocin according to the invention are especially efficient in topical treatment of viral infections Herpes simplex and Herpes zoster.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HRP20170897AA HRP20170897A2 (hr) | 2017-06-13 | 2017-06-13 | Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HRP20170897AA HRP20170897A2 (hr) | 2017-06-13 | 2017-06-13 | Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20170897A2 true HRP20170897A2 (hr) | 2018-12-28 |
Family
ID=64899134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HRP20170897AA HRP20170897A2 (hr) | 2017-06-13 | 2017-06-13 | Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo |
Country Status (1)
Country | Link |
---|---|
HR (1) | HRP20170897A2 (hr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476435A (zh) * | 2021-08-25 | 2021-10-08 | 山东省农业科学院畜牧兽医研究所 | 莫匹罗星在制备抗牛流行热病毒药物中的应用 |
-
2017
- 2017-06-13 HR HRP20170897AA patent/HRP20170897A2/hr not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113476435A (zh) * | 2021-08-25 | 2021-10-08 | 山东省农业科学院畜牧兽医研究所 | 莫匹罗星在制备抗牛流行热病毒药物中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR116415A2 (es) | Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas | |
CL2018000033A1 (es) | Composición para destapar una nariz tapada que tiene actividad antiviral. | |
CL2017002727A1 (es) | Composiciones de ácido obeticólico y métodos de uso | |
CL2015003686A1 (es) | Derivados de pirrolo[3,2-d]pirimidina para el tratamiento de infecciones víricas y otras enfermedades | |
CL2020001762A1 (es) | Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. (divisional solicitud 201902464) | |
BR112015020118A2 (pt) | derivados de 2-aminopirimidina para o tratamento de infecções virais | |
PH12016500024A1 (en) | Bromodomain inhibitor | |
MX2016002589A (es) | Composicion farmaceutica que contiene compuesto de pirimidina como ingrediente activo. | |
BR112015018087A8 (pt) | composto, composição farmacêutica e uso | |
UY35391A (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-cianometil)-amidas sustituidas inhibidores de catepsina c | |
CL2022003733A1 (es) | Análogos de nucleósido de 1’-ciano y usos de los mismos | |
PH12016501567A1 (en) | 4`-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication | |
BR112019001768A2 (pt) | moduladores do receptor de spiro-lactamas nmda e usos dos mesmos | |
BR112019001921A2 (pt) | moduladores do receptor nmda de espiro-lactama e seus usos | |
CO2020010193A2 (es) | Una composición farmacéutica para la anemia | |
WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
PH12020550956A1 (en) | Sgc stimulators | |
BR112015005347A2 (pt) | composto, composição farmacêutica, e, método para tratamento ou profilaxia de infecção por hiv ou para tratamento, profilaxia, ou atraso no início de aids | |
WO2018089328A8 (en) | TREATMENT OF CNS DISEASES USING GCS STIMULATORS | |
PH12019501017A1 (en) | Sgc stimulators | |
MX2017013795A (es) | Combinaciones terapeuticas de tratamientos antivirales y antiinflamatorios. | |
BR112019007591A2 (pt) | inibidores de bromodomínios | |
BR112021009078A8 (pt) | Antagonistas substituídos de receptor de adenosina de aminotriazolopirimidina e aminotriazolopirazina, composições farmacêuticas e seus usos | |
HRP20170897A2 (hr) | Topikalna farmaceutska formulacija na bazi mupirocina kao antivirusno sredstvo | |
CL2018002368A1 (es) | Formulaciones de oritavancina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
OBST | Application withdrawn |